sirolimus has been researched along with Conjunctivitis--Allergic* in 2 studies
1 review(s) available for sirolimus and Conjunctivitis--Allergic
1 trial(s) available for sirolimus and Conjunctivitis--Allergic
1 other study(ies) available for sirolimus and Conjunctivitis--Allergic
Article | Year |
---|---|
Rapamycin attenuates Th2-driven experimental allergic conjunctivitis.
Allergic conjunctivitis is mediated by eosinophilic infiltration and Th2 type immune responses. This study aims to elucidate the role of rapamycin, mTOR inhibitor, on OVA-induced experimental allergic conjunctivitis (EAC). Rapamycin administration intraperitoneally markedly reduced clinical signs, total and OVA-specific IgE and IgG1/G2a ratio in serum, and conjunctival eosinophilic infiltration. Infiltrations of CD11c Topics: Animals; Conjunctiva; Conjunctivitis, Allergic; Female; Gene Expression; Immunoglobulin E; Immunoglobulin G; Immunosuppressive Agents; Mice, Inbred BALB C; Ovalbumin; Sirolimus; Th2 Cells | 2018 |